Antitumor and antimetastatic activities of Rhizoma Paridis saponinsSHULI MAN; WENYUAN GAO; YANJUN ZHANG et al.Steroids. 2009, Vol 74, Num 13-14, pp 1051-1056, issn 0039-128X, 6 p.Article

Antimetastatic activity of a novel mechanism-based gelatinase inhibitorKRÜGER, Achim; ANT, Matthias J. E; GERG, Michael et al.Cancer research (Baltimore). 2005, Vol 65, Num 9, pp 3523-3526, issn 0008-5472, 4 p.Article

Rationale for the development of antithrombotic, antimetastatic and fibrinolytic durgs: a mechanic point of view, international workshop, Montebello PQ, Canada, April 28-May 1, 1987BASTIDA, E. Ed; BUCHANAN, M. R; OFOSU, F. A et al.Seminars in thrombosis and hemostasis. 1988, Vol 14, Num 1, pp 1-132, issn 0094-6176Conference Proceedings

Evidence of antiangiogenic and antimetastatic activities of the recombinant disintegrin domain of metargidinTROCHON-JOSEPH, Véronique; MARTEL-RENOIR, Dominique; LEGRAND, Chantal et al.Cancer research (Baltimore). 2004, Vol 64, Num 6, pp 2062-2069, issn 0008-5472, 8 p.Article

RRM1-induced metastasis suppression through PTEN-regulated pathwaysGAUTAM, Ashish; LI, Zhan-Rong; BEPLER, Gerold et al.Oncogene (Basingstoke). 2003, Vol 22, Num 14, pp 2135-2142, issn 0950-9232, 8 p.Article

Cytotoxic, Antitumour and Antimetastatic Activity of Two New Polyacetylenes Isolated from Vernonia scorpioides (Lam.) PersKLEIN, Juliana B; NOWILL, Alexandre E; FRANCHI, Gilberto C et al.Basic & clinical pharmacology & toxicology (Print). 2013, Vol 113, Num 5, pp 307-315, issn 1742-7835, 9 p.Article

Warfarin inhibition of metastasis: the role of anticoagulationMCCULLOCH, P; GEORGE, W. D.British journal of surgery. 1987, Vol 74, Num 10, pp 879-883, issn 0007-1323Article

Antimetastatic Activity of a Preventive Cancer VaccineNANNI, Patrizia; NICOLETTI, Giordano; IEZZI, Manuela et al.Cancer research (Baltimore). 2007, Vol 67, Num 22, pp 11037-11044, issn 0008-5472, 8 p.Article

Antimetastatic effect of prodigiosin through inhibition of tumor invasionJING ZHANG; YALING SHEN; JIANWEN LIU et al.Biochemical pharmacology. 2005, Vol 69, Num 3, pp 407-414, issn 0006-2952, 8 p.Article

Further studies of the therapeutic effects of murine melanoma-specific monoclonal antibodiesLAW, L. W; VIEIRA, W. D; HEARING, V. J et al.Biochimica et biophysica acta. Molecular basis of disease. 1994, Vol 1226, Num 1, pp 105-109, issn 0925-4439Article

Antimetastatic Effects of Blocking PD-1 and the Adenosine A2A ReceptorMITTAL, Deepak; YOUNG, Arabella; STANNARD, Kimberley et al.Cancer research (Chicago, Ill.). 2014, Vol 74, Num 14, pp 3652-3658, issn 0008-5472, 7 p.Article

YIGSR, a synthetic laminin pentapeptide, inhibits experimental metastasis formationIWAMOTO, Y; ROBEY, F. A; GRAF, J et al.Science (Washington, D.C.). 1987, Vol 238, Num 4830, pp 1132-1134, issn 0036-8075Article

Regulatory issues in the evaluation of antimetastatic and other novel anticancer therapiesFRIEDMAN, M. A.Cancer chemotherapy and pharmacology. 1999, Vol 43, pp S100-S103, issn 0344-5704, SUPConference Paper

Inhibition of tumor cell invasion by verapamilYOHEM, K. H; CLOTHIER, J. L; MONTAGUE, S. L et al.Pigment cell research. 1991, Vol 4, Num 5-6, pp 225-233, issn 0893-5785Article

Le point sur la métastase cancéreuse. 3^e congrès international de la Metastasis Research SocietyPOUPON, M. F; BURTIN, P; BERTRAND, S et al.Bulletin du cancer. 1991, Vol 78, Num 5, pp 457-468, issn 0007-4551Article

Invasion and metastasis control : implications for increased therapeutic index of antitumor drugsMAREEL, M; BRACKE, M; BRUYNEEL, E et al.Cancer treatment reviews. 1990, Vol 17, Num 2-3, pp 335-338, issn 0305-7372, 4 p.Article

Interferon-induced alterations in metastatic capacity, class-1 antigen expression and natural killer cell sensitivity of melanoma cellsMCMILLAN, T. J; RAO, J; EVERETT, C. A et al.International journal of cancer. 1987, Vol 40, Num 5, pp 659-663, issn 0020-7136Article

High-performance liquid chromatographic assay for the determination of p-(3,3-dimethyl-1-triazeno)benzoic acid in mouse plasmaFARINA, P; BENFENATI, E; LASSIANI, L et al.Journal of chromatography. 1985, Vol 345, Num 2, pp 323-331, issn 0021-9673Article

Galectin-9 as a prognostic factor with antimetastatic potential in breast cancerIRIE, Akemi; YAMAUCHI, Akira; HIRASHIMA, Mitsuomi et al.Clinical cancer research. 2005, Vol 11, Num 8, pp 2962-2968, issn 1078-0432, 7 p.Article

Is there a role for anti-adhesives as chemosensitizers in the treatment of solid tumours by chemotherapy ? : MetastasesKERBEL, R. S; ST. CROIX, B; RAK, J et al.Bulletin de l'Institut Pasteur. 1994, Vol 92, Num 4, pp 248-256, issn 0020-2452Article

Biological therapy of human cancerGUTTERMAN, J. U.Cancer. 1992, Vol 70, Num 4, pp 906-908, issn 0008-543X, SUPConference Paper

PF-03732010: A Fully Human Monoclonal Antibody against P-Cadherin with Antitumor and Antimetastatic ActivityZHANG, Cathy C; ZHENGMING YAN; MEHTA, Pramod P et al.Clinical cancer research (Print). 2010, Vol 16, Num 21, pp 5177-5188, issn 1078-0432, 12 p.Article

Antimetastatic effect of a lipophilic ascorbic acid derivative with antioxidation through inhibition of tumor invasionJIANWEN LIU; XIAODONG ZHANG; FAN YANG et al.Cancer chemotherapy and pharmacology. 2006, Vol 57, Num 5, pp 584-590, issn 0344-5704, 7 p.Article

Inhibition of experimental metastasis and extracellular matrix degradation by butanol extracts from B16-F1 murine melanomaKEREN, Z; LELAND, F; NAKAJIMA, M et al.Cancer research (Baltimore). 1989, Vol 49, Num 2, pp 295-300, issn 0008-5472Article

Vitamin K-dependent procoagulant in cancer cells: a potential target for the antimetastatic effect of warfarin?DONATI, M. B; RONCAGLIONI, M. C; FALANGA, A et al.Haemostasis. 1986, Vol 16, Num 3-4, pp 288-294, issn 0301-0147Article